This bill directs the Secretary of Health and Human Services to study whether it is feasible to develop an accurate, reliable, standardized test for detecting tuberculosis in tissue from a human cadaver. The measure is aimed at improving post-mortem diagnostics used in forensic, medical examiner, and public health settings. It does not create a new testing program right away; instead, it asks HHS to evaluate whether a dependable national standard can be developed. If enacted, the main effect would be on federal health agencies and professionals who handle autopsies, death investigations, and disease surveillance.
What This Bill Does
- Directs HHS to study a standardized test for detecting tuberculosis in cadaver tissue.
- Focuses on feasibility, accuracy, and reliability rather than creating a new testing mandate.
- Centers on post-mortem diagnosis used by medical examiners, coroners, and public health labs.
- Aims to support better cause-of-death determinations and disease surveillance.
Who This Bill Affects
For most people, this bill would have no immediate direct cost or benefit because it mainly orders a federal feasibility study. The people most likely to notice any effect are medical examiners, coroners, forensic pathologists, and public health labs that may eventually rely on a standardized tuberculosis test for cadaver tissue. If the study leads to a workable national method, it could improve death investigations and infectious-disease tracking, but it would not change anyone’s eligibility for benefits or impose a direct fee right away.
See how this bill affects you — sign in for a personalized analysisWho Supports & Opposes This
- Medical examiners and forensic pathologists They may support the study because inconsistent post-mortem TB testing can make cause-of-death determinations harder and less uniform across jurisdictions. A federal evaluation could identify whether a standard method would improve accuracy and comparability.
- Public health officials They may argue that better post-mortem TB detection would strengthen surveillance and outbreak response. If TB is missed after death, public health investigators may lose an important clue about where infections are occurring.
- Families involved in death investigations They may favor clearer and more reliable testing because it can help resolve unanswered questions about why a loved one died. More dependable results can also matter when exposure investigations or legal determinations depend on the diagnosis.
- Federal budget watchdogs They may question whether a study is the best use of federal resources for a relatively narrow diagnostic issue. Even modest research mandates can add administrative costs without guaranteeing a practical outcome.
- Local coroners and lab administrators They may worry that a future national standard could become another compliance expectation for already stretched offices. If the study leads to implementation guidance, smaller jurisdictions could face new equipment, training, or validation costs.
- Laboratory and pathology stakeholders concerned about overlap They may argue that existing clinical, forensic, and public-health testing pathways already cover many TB cases adequately. A separate federal standard could duplicate work unless it clearly fills a gap in post-mortem diagnostics.
Key Implications
-
““conduct a study on the feasibility””
This makes the measure an information-gathering step, not an immediate program or mandate. The practical effect is to assess whether a standardized cadaver TB test can be developed and used reliably.
-
““an accurate and reliable standardized test””
The bill is focused on consistency and performance, which matters for labs that need repeatable results. If a standard is found feasible, it could eventually reduce variation between jurisdictions.
-
““for detecting tuberculosis in tissue from a human cadaver””
The target is post-mortem tissue testing, which is used in autopsies and death investigations. That means the primary users would be forensic and public-health professionals rather than the general public.
-
““and for other purposes””
This common legislative phrase can allow related technical or administrative provisions, but it does not itself specify a separate benefit or mandate. Any concrete downstream effect would depend on what HHS finds and what Congress does next.
Official Source & Bill Facts
BillBoard checks this page against public Congress.gov metadata, then adds plain-English analysis where available.
- Bill
- HR 9561
- Congress
- 119th Congress
- Official title
- To direct the Secretary of Health and Human Services to conduct a study on the feasibility of developing an accurate and reliable standardized test for detecting tuberculosis in tissue from a human cadaver, and for other purposes.
- Policy area
- Healthcare
- Latest action
- Referred to the House Committee on Energy and Commerce. (June 30, 2026)
- Last updated
- July 1, 2026
Latest Status
June 30, 2026
Referred to the House Committee on Energy and Commerce.
Related Bills
Take Action
Get more from BillBoard
Free tools to understand, respond to, and track this bill.
Ask AI about this billData sourced from api.congress.gov.